medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2011, Número 3

<< Anterior Siguiente >>

Dermatología Cosmética, Médica y Quirúrgica 2011; 9 (3)


UVA-1 para esclerodermia lineal infantil: primer reporte mexicano

Poletti VED, Chávez FMA, Méndez BSI, Muñoz SR, Morales MA

Idioma: Español
Referencias bibliográficas: 31
Paginas: 196-200
Archivo PDF: 142.59 Kb.


RESUMEN

Paciente femenino de 9 años de edad con esclerodermia lineal, localizada en extremidad superior derecha, y disminución de los arcos de movilidad. Presentó respuesta desfavorable a tratamiento con mometasona al 0.1%, futicasona 0.05%, alquitrán de hulla, urea, y ácido salicílico. Se manejó con fototerapia de luz ultravioleta tipo UVA-1 segmentaria de 340 nm, modalidad baja, con vigilancia ultrasonográfica. En un periodo de tres meses se obtuvo involución completa de la esclerosis, con recuperación de la movilidad articular.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Laguna-Argente C, García-Melgares ML, Febrer-Bosch I. “Morfea infantil”. Piel 2009; 24(1): 28-34.

  2. Fernández-Bussy R, Gatti CF, Porta-Guardia C. Fundamentos en Dermatología Clínica. 1a ed. Buenos Aires, Ediciones Journal, 2011: 229-39.

  3. Peterson LS, Nelson AM, Su WP. “Classification of morphea (localized scleroder ma)”. Mayo Clin Proc 1995; 70: 1068-76.

  4. Vierra E, Cunningham B. “Morphea and localized scleroderma in children”. Sem Cutan Med Surg 1999; 18: 210-25.

  5. Hunzelmann N, Krieg T. “Scleroderma: from pathophysiology to novel therapeutic approaches”. Exp Dermatol 2010; 19: 393-400.

  6. Dutz J. “Treatment options for localized scleroderma”. Skin Therapy Lett 2000; 5: 3-5.

  7. Zulian F, Athreya B. “Treatment of localized scleroderma in childhood”. Br J Dermatol 2007; 156: 1364.

  8. Poletti ED, Moreno GJ, Castillo VF, Amaya M, et al. “Propuesta de guías mexicanas de fototerapia y fotoquimioterapia”. Dermatología Rev Mex 2002; 46(5): 217-223.

  9. Kerscher M, Volkenandt M, Gruss C, Reuther T, Kobyletzki G, Freitag M, et al. “Low dose UVA phototherapy for localized scleroderma”. J Am Acad Dermatol 1998; 38: 21-34.

  10. Dawe RS. “Ultraviolet A1 phototherapy”. Br J Dermatol 2003; 148: 626- 637.

  11. Kollmar AA, Mempel M, Hein R, Ring J, Eberlein B. “Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective study”. Br J Dermatol 2010; 162: 445-447.

  12. Kerschner M, Volkenandt M, Gruss C, Reuther T, von Kobyletzki G, Freitag M, et al. “Low-dose UVA1 phototherapy for treatment of localized scleroderma”. J Am Acad Dermatol 1998; 38: 21-26.

  13. Scharffetter K, Wlaschek M, Hogg A, Schothost A, Goerz G, Krieg T, et al. “UVA irradiation induced collagenase in human dermal fibroblasts in vitro and in vivo”. Arch Dermatol 1991; 283: 506-511.

  14. Tuchinda C, Kerr HA, Taylor CR, Jacobe H, et al. “UVA1 phototherapy for cutaneous diseases: an experience of 92 cases in the United States”. Photodermatol Photoimmunol Photomed 2006; 22: 247-253.

  15. Gruss CJ, Von Kobyletzki G, Behrens-Williams SC, Lininger J, et al. “Effects of low dose ultraviolet A-1 on morphea”. Photodermatol Photoimmunol Photomed 2001; 17: 149-55.

  16. Rosenkranz M, Agle L, Efthimiou P, Lehman T. “Systemic and localized scleroderma in children. Current and future treatment options”. Pediatr Drugs 2006; 8: 85-97.

  17. Kreuter A, Krieg T, Worm M, Wenzel J, Gambichler T, Kuhn, et al. “Diagnosis and Therapy of Localized Scleroderma”. JDDG 2009; 7: S1- S12: 1610-1614.

  18. Zulian F, Vallongo C, Woo P, et al. “Localized scleroderma in childhood is not just a skin disease”. Arthritis Rheum 2005; 52: 2873-8122.

  19. Mayorquin FJ, McCurley TL, Levernier JE, Myers LK, Becker JA, Graham TP, et al. “Progression of childhood linear scleroderma to fatal systemic sclerosis”. J Rheumatol 1994; 21: 1955-1957.

  20. Dytoc M, Ting PT, Man J, Sawyer P, Rionitto L. “First case series on the use of imiquimod for morphoea”. Br J Dermatol 2005; 153: 815-820.

  21. Myers SL, Cohen JS, Sheets PW. “B-mode ultrasound evaluation of skin thickness in progressive systemic sclerosis”. J Rheumatol 1986; 13: 577-580.

  22. Li SC, Liebling MS, Haines KA, Weiss JE, Prann A. “Initial evaluation of an ultrasound measure for evaluating the activity of skin lesions in pediatric localized scleroderma”. Arthritis Care Res (Hoboken) 2010; Nov 30.

  23. Black CM. “Prognosis and management of scleroderma and sclerodermalike disorders in children”. Clin Exp Rheumatol 1994; 12(Suppl 10): S75-S81.

  24. Zulian F, Athreya B. “Treatment of localized scleroderma in childhood”. Br J Dermatol 2007; 156: 1364.

  25. Cunningham BB, Landello ID, Langman C, Sailer DE, Paller AS. “Topical calcipotriol for morphea/linear scleroderma”. J Am Dermatol 1998; 39: 211-215.

  26. Kerscher M, Volkenandt M, Meurer M, Lehmann P, Plewig G, Rocken M. “Treatment of localised scleroderma with PUVA bath photochemotherapy” [letter]. Lancet 1994; 343: 1233.

  27. Kerscher M, Dirschka T, Volkenandt M. “Treatment of localized scleroderma by UVA1 phototherapy”. Lancet 1995; 346: 1166.

  28. Gruss C, Reed JA, Altmeyer P, McNutt NS, Kerscher M. “Induction of interstitial collagenase (MMP-1) by UVA-1 phototherapy in morphea fibroblasts”. Lancet 1997; 350: 1295-1296.

  29. Andres C, Kollmar A, Mempel M, Hein R. “Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective study”. Br J Dermatol 2010 Feb 1; 162(2): 445- 447.

  30. Jacobe HT, Cayce R, Nguyen J. “UVA1 phototherapy is effective in darker skin: a review of 101 patients of Fitzpatrick skin types I-V”. Br J Dermatol 2008; 159(3): 691-696.

  31. Kreuter A, Hyun J, Stucker M, Sommer A, Altmeyer P, Gambichler T. “A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma”. J Am Acad Dermatol 2006; 54: 440-447.




2020     |     www.medigraphic.com